AMLODIPINE BESYLATE

AMLODIPINE BESYLATE was reported 147846 times

AMLODIPINE BESYLATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL HIATUS HERNIA 113 0.4956
1 NEUROLOGIC NEGLECT SYNDROME 220 0.3957
2 CAROTID ARTERY THROMBOSIS 224 0.2638
3 ADJUSTMENT DISORDER 220 0.1692
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 168 0.1582
5 NEPHROGENIC ANAEMIA 724 0.1561
6 MULTIPLE DRUG THERAPY 114 0.1512
7 HYPERPARATHYROIDISM SECONDARY 367 0.1463
8 BLOOD PRESSURE INADEQUATELY CONTROLLED 668 0.1109
9 NASAL OEDEMA 188 0.1040
10 SEDATION COMPLICATION 265 0.1038
11 ESSENTIAL HYPERTENSION 170 0.0928
12 PERSONALITY DISORDER 241 0.0919
13 GINGIVAL HYPERTROPHY 136 0.0896
14 CREATININE RENAL CLEARANCE DECREASED 325 0.0811
15 REBOUND ACID HYPERSECRETION 230 0.0760
16 NEPHROGENIC SYSTEMIC FIBROSIS 223 0.0737
17 SCHIZOAFFECTIVE DISORDER 128 0.0717
18 END STAGE RENAL DISEASE 1212 0.0664
19 DISTRIBUTIVE SHOCK 150 0.0662
20 BLOOD PRESSURE SYSTOLIC ABNORMAL 151 0.0610
21 BURNS SECOND DEGREE 101 0.0575
22 SKIN INDURATION 118 0.0569
23 BREATH SOUNDS ABNORMAL 280 0.0567
24 HYPERPHOSPHATAEMIA 122 0.0567
25 CAROTID ARTERY STENOSIS 186 0.0532
26 RENAL FAILURE CHRONIC 401 0.0521
27 BENIGN PROSTATIC HYPERPLASIA 265 0.0513
28 HYPERLIPIDAEMIA 602 0.0503
29 BLOOD PRESSURE DIASTOLIC ABNORMAL 118 0.0463
30 ISCHAEMIC CARDIOMYOPATHY 141 0.0459
31 LACUNAR INFARCTION 106 0.0442
32 VENTRICULAR HYPERTROPHY 110 0.0438
33 HEMIPLEGIA 360 0.0432
34 ARTERIAL OCCLUSIVE DISEASE 338 0.0430
35 BLOOD PHOSPHORUS INCREASED 115 0.0421
36 BLOOD CALCIUM DECREASED 473 0.0420
37 GANGRENE 252 0.0418
38 AORTIC STENOSIS 143 0.0410
39 DIASTOLIC DYSFUNCTION 125 0.0405
40 CORONARY ARTERY DISEASE 1214 0.0401
41 SKIN HYPERTROPHY 112 0.0398
42 CHRONIC KIDNEY DISEASE 2987 0.0393
43 ANGINA UNSTABLE 253 0.0389
44 HYPERTONIC BLADDER 111 0.0384
45 LEFT VENTRICULAR HYPERTROPHY 162 0.0378
46 SENSORY LOSS 303 0.0376
47 HYPERURICAEMIA 153 0.0372
48 BLOOD PRESSURE SYSTOLIC INCREASED 725 0.0371
49 ATRIOVENTRICULAR BLOCK FIRST DEGREE 158 0.0364
50 HYPOPNOEA 126 0.0363
51 ORTHOSTATIC HYPOTENSION 632 0.0363
52 PLEURITIC PAIN 100 0.0362
53 ARTERIOSCLEROSIS CORONARY ARTERY 240 0.0362
54 SUPRAVENTRICULAR EXTRASYSTOLES 122 0.0361
55 RENAL FUNCTION TEST ABNORMAL 166 0.0357
56 HAEMORRHAGIC ANAEMIA 156 0.0355
57 BRONCHIECTASIS 239 0.0354
58 BLOOD UREA INCREASED 592 0.0353
59 DIVERTICULUM INTESTINAL 153 0.0350
60 DIABETIC NEUROPATHY 173 0.0349
61 FULL BLOOD COUNT ABNORMAL 361 0.0341
62 PROTEIN URINE PRESENT 169 0.0339
63 HYPERCHOLESTEROLAEMIA 322 0.0333
64 CARDIAC MURMUR 285 0.0329
65 DIVERTICULUM 233 0.0328
66 GLUCOSE TOLERANCE IMPAIRED 192 0.0324
67 CORONARY ARTERY STENOSIS 163 0.0324
68 RENAL CYST 255 0.0321
69 SNORING 121 0.0320
70 BLOOD PRESSURE DIASTOLIC DECREASED 235 0.0318
71 NOCTURIA 383 0.0315
72 ARTERIOSCLEROSIS 296 0.0314
73 DIFFICULTY IN WALKING 108 0.0314
74 SINUS CONGESTION 424 0.0314
75 OEDEMA 1689 0.0311
76 RENAL INJURY 922 0.0310
77 OBSTRUCTIVE AIRWAYS DISORDER 344 0.0309
78 MOTOR DYSFUNCTION 315 0.0309
79 BLOOD URIC ACID INCREASED 178 0.0308
80 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 156 0.0308
81 CAROTID ARTERY OCCLUSION 112 0.0307
82 BLOOD PRESSURE DIASTOLIC INCREASED 141 0.0305
83 HEPATIC CYST 103 0.0303
84 NEPHROPATHY 277 0.0296
85 AORTIC VALVE INCOMPETENCE 126 0.0296
86 KIDNEY TRANSPLANT REJECTION 142 0.0296
87 HYPERTENSIVE CRISIS 329 0.0295
88 MUSCLE SPASTICITY 359 0.0292
89 BLOOD CREATINE INCREASED 129 0.0291
90 PERIPHERAL VASCULAR DISORDER 150 0.0291
91 RHINITIS 233 0.0289
92 MITRAL VALVE INCOMPETENCE 327 0.0289
93 TRICUSPID VALVE INCOMPETENCE 228 0.0287
94 AFFECT LABILITY 276 0.0287
95 TONGUE OEDEMA 109 0.0285
96 ATELECTASIS 276 0.0285
97 GOUT 512 0.0285
98 TROPONIN INCREASED 217 0.0285
99 GINGIVAL PAIN 227 0.0285
100 HIATUS HERNIA 368 0.0284
101 SEASONAL ALLERGY 401 0.0283
102 CARDIOMEGALY 348 0.0283
103 RENAL CELL CARCINOMA 138 0.0282
104 ANGINA PECTORIS 808 0.0282
105 SPINAL OSTEOARTHRITIS 246 0.0280
106 SPINAL COLUMN STENOSIS 132 0.0279
107 RENAL FAILURE ACUTE 1183 0.0279
108 RENAL FAILURE 3683 0.0277
109 BLOOD POTASSIUM DECREASED 833 0.0277
110 BLOOD PRESSURE INCREASED 4233 0.0277
111 RHINITIS ALLERGIC 123 0.0276
112 OEDEMA PERIPHERAL 3366 0.0276
113 MICTURITION URGENCY 313 0.0274
114 BLOOD POTASSIUM INCREASED 444 0.0273
115 PRE-EXISTING CONDITION IMPROVED 170 0.0272
116 RENAL TUBULAR NECROSIS 267 0.0272
117 WHEEZING 1609 0.0271
118 TRANSIENT ISCHAEMIC ATTACK 913 0.0270
119 CARDIAC FAILURE CONGESTIVE 2167 0.0270
120 RALES 153 0.0263
121 SLEEP APNOEA SYNDROME 499 0.0261
122 HAEMATOCRIT DECREASED 517 0.0260
123 BLOOD CALCIUM INCREASED 228 0.0260
124 SPRUE-LIKE ENTEROPATHY 128 0.0259
125 BODY HEIGHT DECREASED 276 0.0258
126 CORONARY ARTERY OCCLUSION 352 0.0256
127 TUBULOINTERSTITIAL NEPHRITIS 481 0.0256
128 BLOOD PRESSURE FLUCTUATION 616 0.0256
129 SINUS DISORDER 504 0.0254
130 GASTRIC ULCER HAEMORRHAGE 140 0.0252
131 DYSLIPIDAEMIA 128 0.0252
132 HEMIPARESIS 426 0.0251
133 MYOCARDIAL ISCHAEMIA 286 0.0251
134 IRON DEFICIENCY 113 0.0251
135 SKIN TIGHTNESS 118 0.0251
136 SINUS BRADYCARDIA 242 0.0250
137 ECONOMIC PROBLEM 378 0.0249
138 COORDINATION ABNORMAL 347 0.0249
139 BLOOD CREATININE INCREASED 1623 0.0248
140 ATRIOVENTRICULAR BLOCK 192 0.0248
141 SKIN HAEMORRHAGE 368 0.0248
142 HYPERTENSION 5232 0.0247
143 DYSPNOEA EXERTIONAL 927 0.0246
144 LARGE INTESTINE POLYP 170 0.0245
145 CORONARY ARTERIAL STENT INSERTION 124 0.0244
146 BUNDLE BRANCH BLOCK RIGHT 112 0.0244
147 CEREBRAL INFARCTION 589 0.0241
148 BUNDLE BRANCH BLOCK LEFT 102 0.0240
149 VITAMIN D DEFICIENCY 232 0.0238
150 RESPIRATORY TRACT INFECTION 618 0.0237
151 ELECTROCARDIOGRAM ABNORMAL 185 0.0236
152 HYPERKALAEMIA 824 0.0235
153 ANOREXIA 301 0.0233
154 RESPIRATORY TRACT CONGESTION 371 0.0233
155 EATING DISORDER 496 0.0233
156 BLOOD SODIUM DECREASED 439 0.0233
157 HYPOVOLAEMIA 136 0.0232
158 BLOOD PRESSURE ABNORMAL 461 0.0232
159 MULTIPLE ALLERGIES 181 0.0231
160 HYPERVOLAEMIA 114 0.0230
161 RED BLOOD CELL SEDIMENTATION RATE INCREASED 254 0.0229
162 INTERVERTEBRAL DISC DEGENERATION 211 0.0228
163 BLOOD MAGNESIUM DECREASED 196 0.0227
164 HYPERKERATOSIS 125 0.0226
165 BLOOD ALBUMIN DECREASED 179 0.0225
166 IRON DEFICIENCY ANAEMIA 208 0.0225
167 AORTIC ANEURYSM 171 0.0225
168 GINGIVAL SWELLING 99 0.0224
169 HAEMODIALYSIS 188 0.0224
170 URINE OUTPUT DECREASED 194 0.0222
171 ANHEDONIA 582 0.0221
172 PRODUCT ADMINISTRATION INTERRUPTED 173 0.0220
173 ACUTE MYOCARDIAL INFARCTION 645 0.0219
174 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1133 0.0217
175 HAEMOGLOBIN INCREASED 99 0.0217
176 UPPER-AIRWAY COUGH SYNDROME 178 0.0216
177 DYSARTHRIA 813 0.0216
178 SKIN ABRASION 102 0.0216
179 CARDIAC VALVE DISEASE 123 0.0215
180 ATRIOVENTRICULAR BLOCK COMPLETE 144 0.0215
181 SHOCK 491 0.0213
182 PROTHROMBIN TIME PROLONGED 127 0.0212
183 HYPOKALAEMIA 980 0.0212
184 MYASTHENIA GRAVIS 171 0.0212
185 HAEMORRHOIDS 412 0.0211
186 ACUTE KIDNEY INJURY 3226 0.0211
187 ULCER 332 0.0208
188 HYPERCALCAEMIA 257 0.0208
189 STENT PLACEMENT 167 0.0207
190 VENTRICULAR EXTRASYSTOLES 215 0.0207
191 RENAL IMPAIRMENT 1731 0.0206
192 HYPOPHOSPHATAEMIA 152 0.0205
193 GENERALISED OEDEMA 254 0.0205
194 ASTHMA 2305 0.0204
195 GLOMERULAR FILTRATION RATE DECREASED 250 0.0203
196 CEREBRAL ISCHAEMIA 104 0.0202
197 HEART RATE DECREASED 708 0.0201
198 CARDIAC PACEMAKER INSERTION 120 0.0201
199 DUODENAL ULCER 142 0.0201
200 RED BLOOD CELL COUNT DECREASED 575 0.0201
201 COLITIS ISCHAEMIC 135 0.0200
202 CATARACT 1191 0.0200
203 BRADYCARDIA 1059 0.0199
204 ATRIAL FIBRILLATION 1941 0.0199
205 ECCHYMOSIS 136 0.0198
206 OBESITY 316 0.0198
207 CORONARY ARTERY BYPASS 114 0.0198
208 EXERCISE TOLERANCE DECREASED 114 0.0198
209 DEPRESSED LEVEL OF CONSCIOUSNESS 783 0.0198
210 HYPONATRAEMIA 1112 0.0197
211 SNEEZING 442 0.0197
212 NEPHROTIC SYNDROME 135 0.0197
213 BLOOD LACTATE DEHYDROGENASE INCREASED 312 0.0197
214 GASTROOESOPHAGEAL REFLUX DISEASE 1584 0.0197
215 FAILURE TO THRIVE 102 0.0196
216 CYSTITIS 623 0.0195
217 PURPURA 173 0.0195
218 ELECTROLYTE IMBALANCE 227 0.0195
219 ACUTE RESPIRATORY FAILURE 374 0.0194
220 RHEUMATOID FACTOR POSITIVE 112 0.0194
221 BLOOD CHOLESTEROL INCREASED 894 0.0192
222 HAIR DISORDER 158 0.0192
223 MELAENA 421 0.0191
224 HYDRONEPHROSIS 143 0.0191
225 DIALYSIS 271 0.0191
226 SKIN NECROSIS 99 0.0191
227 DIZZINESS POSTURAL 185 0.0191
228 ACUTE CORONARY SYNDROME 158 0.0191
229 ANURIA 164 0.0190
230 OLIGURIA 118 0.0190
231 PSYCHOLOGICAL TRAUMA 164 0.0190
232 PROTEINURIA 361 0.0190
233 PULMONARY OEDEMA 850 0.0190
234 COVID-19 PNEUMONIA 224 0.0190
235 BLOOD ALKALINE PHOSPHATASE INCREASED 471 0.0189
236 PLEURAL EFFUSION 1153 0.0189
237 GINGIVITIS 102 0.0189
238 PRODUCTIVE COUGH 901 0.0189
239 OSTEOARTHRITIS 799 0.0188
240 PAROSMIA 142 0.0188
241 PHARYNGOLARYNGEAL PAIN 100 0.0188
242 DIABETES MELLITUS INADEQUATE CONTROL 333 0.0188
243 BODY TEMPERATURE DECREASED 184 0.0187
244 DECUBITUS ULCER 152 0.0186
245 CARDIAC FAILURE ACUTE 124 0.0186
246 BASAL CELL CARCINOMA 290 0.0186
247 POLLAKIURIA 775 0.0186
248 TYPE 2 DIABETES MELLITUS 624 0.0185
249 NERVE COMPRESSION 171 0.0185
250 INCREASED TENDENCY TO BRUISE 170 0.0185
251 UPPER GASTROINTESTINAL HAEMORRHAGE 310 0.0184
252 BLOOD PRESSURE DECREASED 1224 0.0184
253 ANGIOPATHY 103 0.0184
254 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 312 0.0184
255 CEREBROVASCULAR ACCIDENT 3111 0.0183
256 EXTRASYSTOLES 128 0.0183
257 ARTHRITIS 1441 0.0183
258 BLOOD CREATINE PHOSPHOKINASE INCREASED 526 0.0183
259 HAIR COLOUR CHANGES 227 0.0182
260 EMPHYSEMA 184 0.0182
261 CARDIOGENIC SHOCK 261 0.0182
262 LOWER GASTROINTESTINAL HAEMORRHAGE 134 0.0181
263 MULTIPLE INJURIES 114 0.0181
264 MAJOR DEPRESSION 132 0.0180
265 DIABETES MELLITUS 1370 0.0180
266 RENAL DISORDER 834 0.0179
267 HAEMOGLOBIN DECREASED 1833 0.0178
268 ROTATOR CUFF SYNDROME 228 0.0177
269 HYPOTENSION 3557 0.0177
270 JOINT INJURY 378 0.0177
271 HYPERGLYCAEMIA 642 0.0176
272 BALANCE DISORDER 1522 0.0176
273 DRUG ERUPTION 312 0.0176
274 FLANK PAIN 165 0.0176
275 MACULAR DEGENERATION 210 0.0176
276 HEART RATE IRREGULAR 397 0.0176
277 SKIN LACERATION 191 0.0175
278 PULMONARY HYPERTENSION 365 0.0175
279 PULMONARY MASS 261 0.0175
280 BLOOD TRIGLYCERIDES INCREASED 309 0.0175
281 PERICARDIAL EFFUSION 404 0.0175
282 CHEST PAIN 3222 0.0174
283 APHASIA 524 0.0173
284 VASCULITIS 202 0.0173
285 FULL BLOOD COUNT DECREASED 349 0.0173
286 MULTI-ORGAN FAILURE 299 0.0173
287 ATRIAL FLUTTER 138 0.0173
288 POLYP 113 0.0172
289 BLOOD URINE PRESENT 327 0.0172
290 HYPOGLYCAEMIA 835 0.0172
291 HYPOXIA 605 0.0172
292 SPUTUM DISCOLOURED 162 0.0171
293 CARPAL TUNNEL SYNDROME 239 0.0170
294 CHOLECYSTITIS 203 0.0170
295 LEFT VENTRICULAR DYSFUNCTION 114 0.0170
296 RESPIRATORY RATE INCREASED 151 0.0170
297 INFUSION SITE SWELLING 107 0.0170
298 PULMONARY CONGESTION 224 0.0170
299 ASPARTATE AMINOTRANSFERASE INCREASED 902 0.0170
300 EXOSTOSIS 155 0.0170
301 PNEUMONIA 5482 0.0169
302 CARDIOMYOPATHY 250 0.0169
303 GASTRIC ULCER 321 0.0169
304 CONSTIPATION 3683 0.0169
305 DEHYDRATION 2250 0.0169
306 PULMONARY FIBROSIS 323 0.0168
307 ANAEMIA 3207 0.0168
308 HOSPICE CARE 166 0.0168
309 LOW DENSITY LIPOPROTEIN INCREASED 130 0.0168
310 BACK DISORDER 273 0.0168
311 GINGIVAL BLEEDING 229 0.0168
312 BLOOD IRON DECREASED 199 0.0168
313 FEAR 451 0.0168
314 EYE PAIN 946 0.0167
315 METABOLIC ACIDOSIS 534 0.0167
316 CELLULITIS 841 0.0167
317 SKIN ULCER 431 0.0167
318 LEUKOCYTOSIS 301 0.0166
319 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 386 0.0165
320 REFUSAL OF TREATMENT BY PATIENT 108 0.0165
321 HEPATIC FUNCTION ABNORMAL 617 0.0165
322 GASTRITIS 434 0.0165
323 FALL 5476 0.0164
324 INCONTINENCE 173 0.0164
325 BRONCHITIS 1211 0.0163
326 COUGH 4582 0.0163
327 RIB FRACTURE 336 0.0163
328 MUSCULOSKELETAL DISCOMFORT 281 0.0163
329 DRUG LEVEL INCREASED 270 0.0163
330 OESOPHAGITIS 178 0.0163
331 IMPAIRED QUALITY OF LIFE 234 0.0163
332 PERIPHERAL SWELLING 2507 0.0163
333 VITAMIN D DECREASED 139 0.0162
334 PROSTATIC SPECIFIC ANTIGEN INCREASED 224 0.0162
335 HYPERTHYROIDISM 235 0.0162
336 SPINAL COMPRESSION FRACTURE 134 0.0162
337 RECTAL HAEMORRHAGE 694 0.0161
338 OSTEOPENIA 245 0.0161
339 INFUSION SITE PAIN 208 0.0161
340 POSTOPERATIVE WOUND INFECTION 109 0.0161
341 FAECES SOFT 117 0.0161
342 INITIAL INSOMNIA 165 0.0161
343 PYELONEPHRITIS 139 0.0160
344 ORAL PAIN 359 0.0160
345 WHITE BLOOD CELL COUNT INCREASED 615 0.0160
346 MENTAL STATUS CHANGES 445 0.0160
347 RHABDOMYOLYSIS 666 0.0160
348 C-REACTIVE PROTEIN INCREASED 580 0.0159
349 PELVIC FRACTURE 124 0.0159
350 HAEMATURIA 544 0.0159
351 GAMMA-GLUTAMYLTRANSFERASE INCREASED 352 0.0159
352 NEURALGIA 386 0.0159
353 MUSCULAR WEAKNESS 1804 0.0159
354 VENTRICULAR FIBRILLATION 176 0.0158
355 RHINORRHOEA 1022 0.0158
356 DIVERTICULITIS 438 0.0158
357 HEPATIC STEATOSIS 293 0.0157
358 GASTROENTERITIS 229 0.0157
359 INFUSION SITE ERYTHEMA 132 0.0156
360 MYOCARDIAL INFARCTION 2722 0.0156
361 INTERVERTEBRAL DISC PROTRUSION 341 0.0156
362 EYE INFECTION 176 0.0156
363 CHOLELITHIASIS 511 0.0156
364 DYSURIA 573 0.0156
365 HYPOALBUMINAEMIA 121 0.0155
366 SCIATICA 248 0.0155
367 ASPIRATION 170 0.0155
368 ASTHENIA 5824 0.0155
369 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 159 0.0155
370 LIGAMENT SPRAIN 153 0.0155
371 PNEUMONIA BACTERIAL 142 0.0155
372 SWOLLEN TONGUE 483 0.0154
373 LIMB INJURY 420 0.0154
374 DEMENTIA 432 0.0154
375 SEDATION 404 0.0154
376 SYNCOPE 1543 0.0154
377 GASTROINTESTINAL HAEMORRHAGE 1285 0.0154
378 SUBDURAL HAEMATOMA 220 0.0154
379 DENTAL CARIES 170 0.0154
380 JOINT SWELLING 1855 0.0154
381 SHOCK HAEMORRHAGIC 125 0.0153
382 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 737 0.0153
383 CONTUSION 1476 0.0153
384 CHEST DISCOMFORT 1566 0.0153
385 ALTERED STATE OF CONSCIOUSNESS 331 0.0153
386 BACTERIAL INFECTION 284 0.0152
387 LUNG INFILTRATION 134 0.0152
388 JOINT RANGE OF MOTION DECREASED 203 0.0151
389 DYSPHONIA 882 0.0151
390 HAEMORRHAGIC STROKE 117 0.0150
391 ONYCHOCLASIS 103 0.0150
392 URINARY TRACT INFECTION 2551 0.0149
393 SCAR 256 0.0149
394 PALPITATIONS 1749 0.0149
395 INTERNATIONAL NORMALISED RATIO INCREASED 425 0.0149
396 FLUID OVERLOAD 216 0.0148
397 FOOT FRACTURE 281 0.0148
398 PRESYNCOPE 360 0.0148
399 GLAUCOMA 285 0.0148
400 LACERATION 139 0.0148
401 HYPOTHYROIDISM 472 0.0148
402 UPPER RESPIRATORY TRACT INFECTION 682 0.0147
403 ERECTILE DYSFUNCTION 378 0.0147
404 CLOSTRIDIUM DIFFICILE COLITIS 156 0.0147
405 INTERSTITIAL LUNG DISEASE 712 0.0147
406 ABASIA 363 0.0147
407 WRIST FRACTURE 176 0.0147
408 EPISTAXIS 1098 0.0147
409 DRY MOUTH 1189 0.0146
410 SMALL INTESTINAL OBSTRUCTION 180 0.0146
411 FLATULENCE 826 0.0146
412 MUSCLE STRAIN 126 0.0145
413 POLYURIA 119 0.0145
414 ALANINE AMINOTRANSFERASE INCREASED 892 0.0145
415 HEAD INJURY 459 0.0145
416 HAIR TEXTURE ABNORMAL 194 0.0145
417 PLATELET COUNT INCREASED 189 0.0145
418 MALNUTRITION 162 0.0145
419 URINARY INCONTINENCE 428 0.0144
420 OSTEOPOROSIS 592 0.0144
421 FAECES DISCOLOURED 312 0.0144
422 RESTLESS LEGS SYNDROME 261 0.0143
423 BURSITIS 174 0.0143
424 COGNITIVE DISORDER 669 0.0143
425 OXYGEN SATURATION DECREASED 805 0.0143
426 SINUSITIS 1468 0.0143
427 LYMPHOEDEMA 99 0.0143
428 DECREASED APPETITE 3324 0.0143
429 UROSEPSIS 132 0.0143
430 TOOTH DISORDER 318 0.0143
431 SINUS TACHYCARDIA 203 0.0143
432 PLATELET COUNT DECREASED 1521 0.0143
433 ASCITES 419 0.0142
434 DYSSTASIA 416 0.0142
435 SUBARACHNOID HAEMORRHAGE 145 0.0142
436 RETINAL HAEMORRHAGE 101 0.0142
437 ILEUS 176 0.0141
438 DYSPNOEA 8012 0.0141
439 ANKLE FRACTURE 219 0.0141
440 DISSEMINATED INTRAVASCULAR COAGULATION 199 0.0141
441 ARRHYTHMIA 669 0.0141
442 VERTIGO 861 0.0141
443 MYOPATHY 122 0.0141
444 NERVE INJURY 157 0.0141
445 URINARY RETENTION 471 0.0141
446 TOOTH INFECTION 186 0.0141
447 BLADDER DISORDER 140 0.0141
448 OCULAR DISCOMFORT 158 0.0141
449 HEREDITARY ANGIOEDEMA 151 0.0141
450 WEIGHT FLUCTUATION 147 0.0140
451 TOOTH ABSCESS 143 0.0140
452 OSTEOMYELITIS 254 0.0140
453 EYE HAEMORRHAGE 187 0.0140
454 PNEUMONIA ASPIRATION 349 0.0140
455 MUSCULOSKELETAL CHEST PAIN 216 0.0139
456 BONE DISORDER 254 0.0139
457 ADRENAL INSUFFICIENCY 169 0.0139
458 POST PROCEDURAL COMPLICATION 267 0.0139
459 POOR QUALITY SLEEP 299 0.0139
460 BACK PAIN 3225 0.0139
461 AGEUSIA 346 0.0139
462 CONFUSIONAL STATE 2240 0.0138
463 CEREBRAL HAEMORRHAGE 495 0.0138
464 COAGULOPATHY 230 0.0138
465 HAEMOPTYSIS 385 0.0138
466 FLUID RETENTION 701 0.0138
467 NEUTROPHIL COUNT INCREASED 141 0.0138
468 ESCHERICHIA INFECTION 113 0.0137
469 SUDDEN DEATH 145 0.0137
470 TOXIC EPIDERMAL NECROLYSIS 208 0.0137
471 NEUROPATHY PERIPHERAL 1301 0.0137
472 MIDDLE INSOMNIA 255 0.0136
473 DYSPEPSIA 1343 0.0136
474 HYPOMAGNESAEMIA 190 0.0136
475 PHARMACEUTICAL PRODUCT COMPLAINT 354 0.0136
476 MOBILITY DECREASED 978 0.0136
477 WEIGHT DECREASED 3791 0.0136
478 BOWEL MOVEMENT IRREGULARITY 104 0.0136
479 DRY THROAT 138 0.0136
480 HERNIA 262 0.0135
481 DYSPHAGIA 1286 0.0135
482 RESPIRATORY FAILURE 987 0.0135
483 POST PROCEDURAL INFECTION 110 0.0135
484 ACUTE RESPIRATORY DISTRESS SYNDROME 239 0.0135
485 NECK PAIN 755 0.0135
486 THROAT IRRITATION 605 0.0135
487 TOOTH EXTRACTION 167 0.0134
488 ATAXIA 159 0.0134
489 PEMPHIGOID 101 0.0134
490 DECREASED ACTIVITY 144 0.0133
491 ACIDOSIS 102 0.0133
492 DIZZINESS 6652 0.0133
493 GALLBLADDER DISORDER 238 0.0133
494 FACIAL PAIN 119 0.0133
495 BLINDNESS UNILATERAL 188 0.0133
496 GROIN PAIN 117 0.0133
497 HAEMATOCHEZIA 734 0.0133
498 HOT FLUSH 1001 0.0133
499 HICCUPS 109 0.0133
500 PAIN IN EXTREMITY 3901 0.0132
501 BLOOD TEST ABNORMAL 186 0.0132
502 HEART RATE INCREASED 1310 0.0132
503 GLYCOSYLATED HAEMOGLOBIN INCREASED 332 0.0131
504 STOMATITIS 797 0.0131
505 EOSINOPHILIA 230 0.0131
506 CARDIAC FAILURE 1052 0.0131
507 MUSCLE ATROPHY 166 0.0131
508 IMPAIRED WORK ABILITY 280 0.0131
509 CARDIAC DISORDER 1225 0.0131
510 SUPRAVENTRICULAR TACHYCARDIA 125 0.0130
511 MUSCULOSKELETAL PAIN 684 0.0130
512 LOSS OF CONSCIOUSNESS 1670 0.0130
513 PETECHIAE 136 0.0130
514 FREQUENT BOWEL MOVEMENTS 352 0.0130
515 SKIN DISCOLOURATION 596 0.0130
516 HIP FRACTURE 417 0.0130
517 TASTE DISORDER 263 0.0130
518 HYPOPHAGIA 331 0.0129
519 HAEMATEMESIS 328 0.0129
520 CONCUSSION 100 0.0129
521 THYROID DISORDER 199 0.0129
522 LYMPHOCYTE COUNT DECREASED 228 0.0129
523 BACTERAEMIA 153 0.0129
524 PERIPHERAL COLDNESS 177 0.0129
525 SPINAL DISORDER 122 0.0129
526 FACE OEDEMA 217 0.0129
527 UPPER LIMB FRACTURE 256 0.0128
528 WHITE BLOOD CELL COUNT DECREASED 1390 0.0128
529 PHOTOPHOBIA 241 0.0128
530 ABDOMINAL DISTENSION 1334 0.0128
531 CHROMATURIA 288 0.0127
532 SLUGGISHNESS 130 0.0127
533 APPENDICITIS 119 0.0127
534 MUSCLE TIGHTNESS 206 0.0127
535 RASH PRURITIC 689 0.0127
536 IMPAIRED GASTRIC EMPTYING 173 0.0127
537 COLON CANCER 189 0.0127
538 HYPOCALCAEMIA 240 0.0127
539 FATIGUE 9860 0.0127
540 ACTIVITIES OF DAILY LIVING IMPAIRED 250 0.0126
541 GAIT DISTURBANCE 2409 0.0126
542 HYPOAESTHESIA 1877 0.0125
543 MUSCLE SPASMS 2301 0.0125
544 DERMATITIS CONTACT 143 0.0125
545 NIGHT SWEATS 404 0.0125
546 INFLUENZA 1395 0.0125
547 JOINT DISLOCATION 132 0.0125
548 PRURITUS GENERALISED 270 0.0125
549 MYOSITIS 112 0.0125
550 SKIN DISORDER 416 0.0125
551 EAR DISCOMFORT 128 0.0125
552 DIARRHOEA 8041 0.0124
553 DIPLOPIA 323 0.0124
554 TOOTH FRACTURE 137 0.0124
555 ISCHAEMIC STROKE 221 0.0124
556 LOCAL SWELLING 216 0.0124
557 LIVER DISORDER 549 0.0124
558 LACRIMATION INCREASED 373 0.0123
559 LIMB DISCOMFORT 382 0.0123
560 DRUG INTERACTION 1955 0.0123
561 THIRST 220 0.0123
562 HEPATOMEGALY 121 0.0123
563 HAEMATOMA 319 0.0123
564 BLOOD BILIRUBIN INCREASED 332 0.0123
565 NASOPHARYNGITIS 2265 0.0123
566 HALLUCINATION, VISUAL 259 0.0123
567 INTENTIONAL OVERDOSE 785 0.0122
568 DYSGEUSIA 909 0.0122
569 NEPHROLITHIASIS 560 0.0122
570 VITREOUS FLOATERS 120 0.0122
571 BLOOD COUNT ABNORMAL 185 0.0122
572 RESPIRATORY DISORDER 365 0.0122
573 VENTRICULAR TACHYCARDIA 201 0.0122
574 UNEVALUABLE EVENT 919 0.0121
575 WOUND INFECTION 133 0.0121
576 SWELLING 1136 0.0121
577 SCRATCH 128 0.0121
578 EOSINOPHIL COUNT INCREASED 101 0.0121
579 HERPES ZOSTER 696 0.0121
580 MYALGIA 2057 0.0121
581 DEEP VEIN THROMBOSIS 784 0.0121
582 TINNITUS 554 0.0120
583 FEELING COLD 335 0.0120
584 SEPSIS 1342 0.0120
585 MASS 168 0.0120
586 OROPHARYNGEAL PAIN 1111 0.0120
587 SKIN LESION 329 0.0120
588 INJURY 842 0.0120
589 SECRETION DISCHARGE 150 0.0120
590 CARDIOVASCULAR DISORDER 304 0.0120
591 STAPHYLOCOCCAL INFECTION 395 0.0120
592 BLISTER 672 0.0120
593 BEDRIDDEN 157 0.0119
594 ARTHROPATHY 663 0.0119
595 HEAD DISCOMFORT 211 0.0119
596 NASAL CONGESTION 700 0.0119
597 GASTROENTERITIS VIRAL 215 0.0119
598 DISORIENTATION 469 0.0118
599 UNRESPONSIVE TO STIMULI 305 0.0118
600 RASH MACULAR 412 0.0118
601 INSOMNIA 3136 0.0118
602 PHARYNGITIS 146 0.0118
603 HAEMOLYTIC ANAEMIA 105 0.0117
604 THROMBOSIS 940 0.0117
605 TOOTHACHE 211 0.0116
606 HYPERSOMNIA 334 0.0116
607 PULMONARY THROMBOSIS 127 0.0116
608 LACTIC ACIDOSIS 377 0.0116
609 SKIN HYPERPIGMENTATION 100 0.0116
610 TENDERNESS 121 0.0116
611 SPLENOMEGALY 136 0.0116
612 LUNG DISORDER 568 0.0116
613 LIVER FUNCTION TEST ABNORMAL 337 0.0116
614 LOCALISED INFECTION 280 0.0116
615 VOMITING 5427 0.0115
616 BLOOD THYROID STIMULATING HORMONE INCREASED 106 0.0115
617 ERYTHEMA MULTIFORME 107 0.0115
618 ANXIETY 3264 0.0115
619 MADAROSIS 133 0.0114
620 LABORATORY TEST ABNORMAL 338 0.0114
621 EAR PAIN 222 0.0114
622 DEPRESSION 2594 0.0114
623 DEAFNESS 298 0.0114
624 CHOKING 222 0.0114
625 ABDOMINAL DISCOMFORT 1906 0.0114
626 SKIN FISSURES 222 0.0113
627 COLD SWEAT 200 0.0113
628 AMNESIA 736 0.0113
629 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 100 0.0113
630 BACK INJURY 123 0.0113
631 KNEE ARTHROPLASTY 238 0.0113
632 FOOT DEFORMITY 125 0.0113
633 PAIN 6915 0.0112
634 NERVOUSNESS 588 0.0112
635 MUSCULOSKELETAL STIFFNESS 984 0.0112
636 FEELING JITTERY 214 0.0112
637 HYPOKINESIA 163 0.0112
638 BLOOD GLUCOSE DECREASED 539 0.0112
639 ABDOMINAL PAIN 2610 0.0112
640 CYST 139 0.0112
641 VISION BLURRED 1537 0.0112
642 IRRITABLE BOWEL SYNDROME 240 0.0112
643 PAIN IN JAW 317 0.0112
644 ARTHRALGIA 4637 0.0111
645 ANGIOEDEMA 493 0.0111
646 SLEEP DISORDER 786 0.0111
647 EYELID OEDEMA 129 0.0111
648 MALAISE 4866 0.0111
649 MULTIPLE ORGAN DYSFUNCTION SYNDROME 314 0.0111
650 KIDNEY INFECTION 217 0.0110
651 GASTRIC DISORDER 379 0.0110
652 FEMUR FRACTURE 342 0.0110
653 STEVENS-JOHNSON SYNDROME 245 0.0110
654 ORAL DISCOMFORT 153 0.0110
655 INSURANCE ISSUE 168 0.0110
656 SKIN EXFOLIATION 926 0.0110
657 BRAIN INJURY 110 0.0110
658 PANCREATITIS ACUTE 246 0.0109
659 MOVEMENT DISORDER 351 0.0109
660 ABDOMINAL PAIN UPPER 2249 0.0109
661 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 187 0.0109
662 SPEECH DISORDER 571 0.0109
663 EYE DISCHARGE 113 0.0109
664 JOINT STIFFNESS 285 0.0109
665 TREMOR 1800 0.0108
666 LOWER LIMB FRACTURE 208 0.0108
667 SYNOVITIS 195 0.0108
668 VISUAL ACUITY REDUCED 359 0.0108
669 TRANSFUSION 113 0.0108
670 ELECTROCARDIOGRAM QT PROLONGED 387 0.0107
671 RENAL PAIN 114 0.0107
672 METASTASES TO LUNG 124 0.0107
673 EYE SWELLING 399 0.0107
674 JAUNDICE 288 0.0107
675 PYREXIA 3701 0.0107
676 NAUSEA 8456 0.0107
677 ECZEMA 558 0.0107
678 SOMNOLENCE 2145 0.0106
679 PANCREATITIS 563 0.0106
680 ORAL CANDIDIASIS 140 0.0106
681 SQUAMOUS CELL CARCINOMA 100 0.0106
682 RETCHING 226 0.0106
683 PHARYNGEAL OEDEMA 163 0.0106
684 ENCEPHALOPATHY 260 0.0106
685 SWELLING FACE 689 0.0106
686 RASH GENERALISED 274 0.0106
687 DELUSION 164 0.0105
688 DERMATITIS 221 0.0105
689 NEOPLASM 121 0.0105
690 HEADACHE 6590 0.0105
691 GASTROINTESTINAL DISORDER 941 0.0105
692 PRURITUS 4036 0.0105
693 LETHARGY 603 0.0105
694 WEIGHT INCREASED 2343 0.0105
695 PARKINSONISM 102 0.0105
696 RESTLESSNESS 382 0.0104
697 VIRAL INFECTION 347 0.0104
698 SPINAL PAIN 122 0.0104
699 CIRCULATORY COLLAPSE 177 0.0104
700 FIBROMYALGIA 252 0.0104
701 SCAB 118 0.0103
702 BURNING SENSATION 723 0.0103
703 CHILLS 1208 0.0103
704 PNEUMONITIS 280 0.0103
705 PNEUMOTHORAX 163 0.0103
706 ROAD TRAFFIC ACCIDENT 429 0.0102
707 SEPTIC SHOCK 446 0.0102
708 BLOOD GLUCOSE ABNORMAL 189 0.0102
709 FLUSHING 1040 0.0102
710 TACHYPNOEA 139 0.0102
711 HYPERHIDROSIS 1317 0.0102
712 HIP ARTHROPLASTY 156 0.0102
713 EAR INFECTION 271 0.0102
714 NIGHTMARE 352 0.0102
715 SKIN CANCER 219 0.0102
716 BLOOD GLUCOSE INCREASED 1916 0.0102
717 PLASMA CELL MYELOMA 396 0.0101
718 POOR VENOUS ACCESS 105 0.0101
719 SPINAL OPERATION 125 0.0101
720 ORAL HERPES 198 0.0101
721 METASTASES TO LIVER 178 0.0101
722 PRESCRIBED UNDERDOSE 201 0.0101
723 DELIRIUM 349 0.0100
724 BLOOD GLUCOSE FLUCTUATION 110 0.0100
725 DRUG INTOLERANCE 968 0.0100
726 TREATMENT NONCOMPLIANCE 548 0.0100
727 CANDIDA INFECTION 169 0.0100
728 GASTRIC HAEMORRHAGE 115 0.0100
729 SPINAL FRACTURE 200 0.0100
730 HALLUCINATION 752 0.0100
731 GENERAL PHYSICAL HEALTH DETERIORATION 1154 0.0100
732 LIP SWELLING 332 0.0100
733 PRODUCT USE COMPLAINT 157 0.0100
734 SOPOR 132 0.0100
735 MEMORY IMPAIRMENT 1366 0.0099
736 IMPAIRED DRIVING ABILITY 113 0.0099
737 HYPOACUSIS 427 0.0099
738 FEELING HOT 608 0.0099
739 EJECTION FRACTION DECREASED 154 0.0099
740 HEPATIC ENZYME INCREASED 675 0.0099
741 INTERNAL HAEMORRHAGE 113 0.0099
742 EYE DISORDER 324 0.0098
743 INTESTINAL OBSTRUCTION 371 0.0098
744 NEUTROPHIL COUNT DECREASED 401 0.0098
745 TOXIC SKIN ERUPTION 99 0.0098
746 GLOSSODYNIA 220 0.0098
747 BONE PAIN 575 0.0098
748 IMPAIRED HEALING 322 0.0098
749 LIVER FUNCTION TEST INCREASED 210 0.0098
750 OCULAR HYPERAEMIA 464 0.0098
751 BIPOLAR DISORDER 106 0.0097
752 INFLUENZA LIKE ILLNESS 802 0.0097
753 HEPATIC CIRRHOSIS 183 0.0097
754 FUNGAL INFECTION 324 0.0097
755 ACCIDENT 116 0.0097
756 HAEMORRHAGE INTRACRANIAL 145 0.0097
757 FEELING ABNORMAL 2320 0.0097
758 MOUTH ULCERATION 204 0.0097
759 ABNORMAL DREAMS 267 0.0097
760 IMMUNE SYSTEM DISORDER 127 0.0096
761 INFLAMMATION 496 0.0096
762 RASH 4188 0.0096
763 RASH PAPULAR 215 0.0096
764 PULMONARY EMBOLISM 909 0.0096
765 HYPOAESTHESIA ORAL 144 0.0095
766 HELICOBACTER INFECTION 98 0.0095
767 PALLOR 259 0.0095
768 PANCYTOPENIA 531 0.0095
769 COLITIS 360 0.0095
770 CONVULSION 542 0.0095
771 QUALITY OF LIFE DECREASED 127 0.0095
772 PRODUCT DOSE OMISSION IN ERROR 268 0.0095
773 MEDICATION ERROR 526 0.0095
774 COVID-19 1660 0.0095
775 ERUCTATION 183 0.0094
776 CHOLECYSTECTOMY 108 0.0094
777 NODULE 123 0.0094
778 RESPIRATORY DISTRESS 260 0.0094
779 ABDOMINAL PAIN LOWER 238 0.0094
780 PHOTOSENSITIVITY REACTION 155 0.0094
781 PARAESTHESIA 1476 0.0094
782 HEPATITIS 240 0.0094
783 SKIN INFECTION 105 0.0094
784 TENDONITIS 144 0.0093
785 PARALYSIS 133 0.0093
786 DRY EYE 463 0.0093
787 FEEDING DISORDER 188 0.0093
788 CARDIO-RESPIRATORY ARREST 387 0.0092
789 CLOSTRIDIUM DIFFICILE INFECTION 202 0.0092
790 CARDIAC ARREST 757 0.0092
791 SYSTEMIC LUPUS ERYTHEMATOSUS 325 0.0091
792 DRY SKIN 1219 0.0091
793 TACHYCARDIA 811 0.0091
794 SUICIDE ATTEMPT 553 0.0091
795 INCREASED APPETITE 174 0.0091
796 ILLNESS 938 0.0091
797 BLINDNESS 370 0.0091
798 INTRAOCULAR PRESSURE INCREASED 116 0.0091
799 WOUND 253 0.0090
800 POST PROCEDURAL HAEMORRHAGE 105 0.0090
801 CONDITION AGGRAVATED 2733 0.0090
802 PERITONITIS 186 0.0090
803 SURGERY 523 0.0089
804 THROAT TIGHTNESS 241 0.0089
805 FRACTURE 168 0.0089
806 GAIT INABILITY 294 0.0088
807 RHEUMATOID ARTHRITIS 996 0.0088
808 EYE IRRITATION 504 0.0087
809 LUNG INFECTION 136 0.0087
810 BRAIN FOG 137 0.0087
811 INTENTIONAL DOSE OMISSION 249 0.0087
812 BODY TEMPERATURE INCREASED 177 0.0087
813 DRUG TOXICITY 118 0.0087
814 CENTRAL NERVOUS SYSTEM LESION 119 0.0087
815 EYE PRURITUS 291 0.0087
816 PARANOIA 149 0.0086
817 DEVICE RELATED INFECTION 133 0.0086
818 LYMPHADENOPATHY 305 0.0086
819 INTENTIONAL PRODUCT USE ISSUE 752 0.0086
820 MALIGNANT NEOPLASM PROGRESSION 879 0.0086
821 RASH ERYTHEMATOUS 410 0.0086
822 THROMBOCYTOPENIA 956 0.0085
823 ALOPECIA 1677 0.0085
824 THERAPY NON-RESPONDER 382 0.0085
825 OSTEONECROSIS OF JAW 210 0.0085
826 APHONIA 118 0.0084
827 TENDON RUPTURE 104 0.0084
828 INFUSION RELATED REACTION 558 0.0084
829 CYANOSIS 132 0.0084
830 THINKING ABNORMAL 155 0.0083
831 CONJUNCTIVITIS 154 0.0083
832 TRANSAMINASES INCREASED 184 0.0083
833 PRODUCT DOSE OMISSION ISSUE 2432 0.0083
834 FEBRILE NEUTROPENIA 547 0.0082
835 NO THERAPEUTIC RESPONSE 100 0.0082
836 BRONCHOSPASM 117 0.0082
837 HYPERSENSITIVITY 1517 0.0082
838 HEPATIC FAILURE 246 0.0082
839 WRONG TECHNIQUE IN DRUG USAGE PROCESS 296 0.0081
840 ERYTHEMA 1667 0.0081
841 RASH MACULO-PAPULAR 180 0.0081
842 DYSKINESIA 328 0.0081
843 DISCOMFORT 491 0.0080
844 EMOTIONAL DISTRESS 974 0.0080
845 INFECTION 1155 0.0080
846 ACCIDENTAL OVERDOSE 291 0.0079
847 MYELODYSPLASTIC SYNDROME 115 0.0079
848 DISEASE PROGRESSION 939 0.0079
849 MIGRAINE 757 0.0079
850 COMA 376 0.0079
851 INTENTIONAL DRUG MISUSE 164 0.0078
852 DISABILITY 155 0.0078
853 NEOPLASM PROGRESSION 272 0.0078
854 HAEMORRHAGE 817 0.0078
855 SENSORY DISTURBANCE 125 0.0078
856 VISUAL IMPAIRMENT 957 0.0077
857 THERAPEUTIC RESPONSE UNEXPECTED 346 0.0077
858 INTENTIONAL PRODUCT MISUSE 674 0.0077
859 PARAESTHESIA ORAL 111 0.0077
860 TOXICITY TO VARIOUS AGENTS 1294 0.0077
861 DEPRESSED MOOD 405 0.0077
862 DISTURBANCE IN ATTENTION 413 0.0077
863 METASTASES TO BONE 125 0.0076
864 APATHY 111 0.0076
865 ABSCESS 121 0.0076
866 RESPIRATORY ARREST 209 0.0076
867 DIABETIC KETOACIDOSIS 182 0.0076
868 MUSCULOSKELETAL DISORDER 144 0.0076
869 CONTRAINDICATED PRODUCT ADMINISTERED 229 0.0076
870 HUNGER 104 0.0075
871 PANIC ATTACK 272 0.0075
872 MUSCLE TWITCHING 172 0.0075
873 PULMONARY ARTERIAL HYPERTENSION 108 0.0074
874 MENTAL IMPAIRMENT 180 0.0074
875 ADVERSE DRUG REACTION 663 0.0074
876 PRESCRIBED OVERDOSE 142 0.0073
877 MALIGNANT MELANOMA 98 0.0073
878 PRODUCT DOSE OMISSION 477 0.0073
879 THERAPEUTIC RESPONSE DECREASED 442 0.0073
880 OSTEONECROSIS 235 0.0071
881 PRODUCT ADMINISTRATION ERROR 144 0.0071
882 MULTIPLE FRACTURES 117 0.0071
883 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 506 0.0071
884 PRODUCT USE ISSUE 1334 0.0071
885 HALLUCINATION, AUDITORY 112 0.0070
886 AGRANULOCYTOSIS 130 0.0070
887 DRUG ADMINISTRATION ERROR 214 0.0070
888 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1255 0.0070
889 EMOTIONAL DISORDER 214 0.0069
890 LEUKOPENIA 343 0.0069
891 PRODUCT SUBSTITUTION ISSUE 392 0.0068
892 URTICARIA 1138 0.0068
893 LUNG NEOPLASM MALIGNANT 279 0.0068
894 MENTAL DISORDER 295 0.0068
895 CYTOMEGALOVIRUS INFECTION 112 0.0067
896 COMPLETED SUICIDE 560 0.0067
897 DRUG EFFECT DECREASED 361 0.0067
898 BONE DENSITY DECREASED 209 0.0067
899 NEUTROPENIA 904 0.0066
900 BONE MARROW FAILURE 135 0.0066
901 AGITATION 486 0.0066
902 PSYCHOTIC DISORDER 194 0.0066
903 PSORIASIS 841 0.0064
904 CHOLESTASIS 123 0.0064
905 HOSPITALISATION 975 0.0063
906 PROCEDURAL PAIN 175 0.0063
907 LOWER RESPIRATORY TRACT INFECTION 286 0.0063
908 NERVOUS SYSTEM DISORDER 196 0.0063
909 OFF LABEL USE 5428 0.0062
910 THERAPY INTERRUPTED 442 0.0062
911 PRODUCT USE IN UNAPPROVED INDICATION 1529 0.0062
912 LIVER INJURY 151 0.0061
913 ANAPHYLACTIC SHOCK 158 0.0061
914 CRYING 218 0.0060
915 DRUG DOSE OMISSION 977 0.0059
916 OVERDOSE 1272 0.0059
917 PRODUCT AVAILABILITY ISSUE 134 0.0059
918 ADVERSE EVENT 541 0.0059
919 ANAPHYLACTIC REACTION 324 0.0059
920 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 417 0.0059
921 MULTIPLE SCLEROSIS 279 0.0058
922 PRODUCT PRESCRIBING ERROR 138 0.0058
923 DRUG-INDUCED LIVER INJURY 181 0.0058
924 THERAPEUTIC PRODUCT EFFECT DECREASED 258 0.0058
925 PAIN OF SKIN 155 0.0058
926 NEOPLASM MALIGNANT 384 0.0057
927 ILL-DEFINED DISORDER 347 0.0057
928 DEATH 4915 0.0057
929 DISEASE RECURRENCE 271 0.0057
930 MOOD ALTERED 155 0.0057
931 SEIZURE 653 0.0056
932 DERMATITIS ATOPIC 297 0.0056
933 ABNORMAL BEHAVIOUR 223 0.0056
934 THERAPY CESSATION 288 0.0056
935 MUCOSAL INFLAMMATION 144 0.0055
936 DRUG INEFFECTIVE 7201 0.0055
937 TOOTH LOSS 113 0.0054
938 SEROTONIN SYNDROME 104 0.0054
939 COLITIS ULCERATIVE 241 0.0054
940 IRRITABILITY 324 0.0054
941 BREAST CANCER FEMALE 143 0.0053
942 MOOD SWINGS 170 0.0053
943 GASTRIC CANCER 134 0.0053
944 NEEDLE ISSUE 151 0.0052
945 MULTIPLE SCLEROSIS RELAPSE 355 0.0052
946 ANGER 174 0.0051
947 THERAPEUTIC RESPONSE SHORTENED 170 0.0051
948 PSORIATIC ARTHROPATHY 208 0.0051
949 INCORRECT DRUG ADMINISTRATION DURATION 144 0.0051
950 EXTRAPYRAMIDAL DISORDER 125 0.0050
951 PRODUCT QUALITY ISSUE 680 0.0050
952 INJECTION SITE BRUISING 394 0.0049
953 UNDERDOSE 358 0.0049
954 SUICIDAL IDEATION 446 0.0049
955 PANCREATIC CARCINOMA 138 0.0048
956 INCORRECT DOSE ADMINISTERED 1050 0.0046
957 DRUG EFFECT INCOMPLETE 166 0.0046
958 PRODUCT PRESCRIBING ISSUE 99 0.0045
959 EXPOSURE VIA SKIN CONTACT 116 0.0045
960 TARDIVE DYSKINESIA 124 0.0044
961 INJECTION SITE PAIN 1345 0.0044
962 INJECTION SITE HAEMORRHAGE 344 0.0043
963 EXPIRED PRODUCT ADMINISTERED 142 0.0043
964 AGGRESSION 211 0.0042
965 INJECTION SITE SWELLING 316 0.0041
966 INJECTION SITE PRURITUS 275 0.0041
967 INJECTION SITE MASS 149 0.0040
968 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 221 0.0040
969 EPILEPSY 121 0.0040
970 INJECTION SITE ERYTHEMA 478 0.0038
971 ACNE 291 0.0038
972 BREAST CANCER 356 0.0038
973 PROSTATE CANCER 306 0.0038
974 WITHDRAWAL SYNDROME 158 0.0038
975 DEVICE MALFUNCTION 253 0.0036
976 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 718 0.0035
977 VAGINAL HAEMORRHAGE 153 0.0035
978 INJECTION SITE RASH 103 0.0034
979 DEVICE DISLOCATION 138 0.0032
980 SKIN IRRITATION 143 0.0031
981 EXTRA DOSE ADMINISTERED 124 0.0031
982 SKIN BURNING SENSATION 219 0.0031
983 TREATMENT FAILURE 248 0.0030
984 DRUG ABUSE 247 0.0030
985 DEVICE ISSUE 247 0.0028
986 NO ADVERSE EVENT 472 0.0026
987 INJECTION SITE REACTION 179 0.0026
988 BLADDER CANCER 142 0.0024
989 DRUG WITHDRAWAL SYNDROME 205 0.0023
990 ACCIDENTAL EXPOSURE TO PRODUCT 239 0.0023
991 RENAL CANCER 107 0.0022
992 EXPOSURE DURING PREGNANCY 117 0.0019
993 PRODUCT STORAGE ERROR 117 0.0013
994 DRUG DEPENDENCE 209 0.0013